Mahasti Saghatchian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mahasti Saghatchian has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Abinaya Rajan
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
1 shared publication - Carlos Caldas
Department of Clinical Biochemistry and Institute of Metabolic Science, School of Clinical Medicine, University of Cambridge, Cambridge, UK
1 shared publication - Henri van Luenen
Research – Cluster management, The Netherlands Cancer Institute, Amsterdam, The Netherlands
1 shared publication - Willem H. van Harten
The Netherlands Cancer Institute, PO Box 90203, Amsterdam, 1006 BE, The Netherlands.
1 shared publication
Latest Publications
- Open Access
- 29 October 2013
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 274
Assessing excellence in translational cancer research: a consensus based framework
It takes several years on average to translate basic research findings into clinical research and eventually deliver patient benefits. An expert-based excellence assessment can help improve this process by: identifying high performing Comprehensive Cancer Centres; best practices in translational cancer research; improving the quality and efficiency of the translational cancer research process. This can help build networks of excellent Centres by aiding focused partnerships. In this paper we report on a consensus building exercise that was undertaken to construct an excellence assessment framework for translational cancer research in Europe.
- 29 October 2013
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 274
Open AccessAssessing excellence in translational cancer research: a consensus based framework
It takes several years on average to translate basic research findings into clinical research and eventually deliver patient benefits. An expert-based excellence assessment can help improve this process by: identifying high performing Comprehensive Cancer Centres; best practices in translational cancer research; improving the quality and efficiency of the translational cancer research process. This can help build networks of excellent Centres by aiding focused partnerships. In this paper we report on a consensus building exercise that was undertaken to construct an excellence assessment framework for translational cancer research in Europe.
- 1 February 2009
- Published by Springer Nature in Oncomagazine
- Vol. 3 (1) , 6-7
Fédérer la recherche européenne
- 1 February 2009
- Published by Springer Nature in Oncomagazine
- Vol. 3 (1) , 6-7
Fédérer la recherche européenne